~~<i id='86C4A4693A'><strike id='86C4A4693A'><tt id='86C4A4693A'><pre id='86C4A4693A'></pre></tt></strike></i>~~

Home» focus» knowledge

knowledge

author：Wikipedia 2025-10-06 10:48:22 Page View：1677

It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Readout: Lenmeldy, GLP
Next article： Activists slam private health insurers over coverage restrictions

explore

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

WinMcNamee/GettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiot

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

Can CDC director Mandy Cohen drive consensus in Washington?

MandyCohen,seenhereduringabriefinginRaleigh,servedasNorthCarolina’ssecretaryofhealthandhumanservices